Tango plans Phase 3 pancreatic cancer study after combo success

June 8, 2026 10:07 AM EDT R&D Tan­go plans Phase 3 pan­cre­at­ic can­cer study af­ter com­bo suc­cess Max Gelman Senior Editor Will 2026 be re­mem­bered as the year when pan­cre­at­ic can­cer fi­nal­ly be­came treat­able? Fol­low­ing Rev­o­lu­tion Med­i­cines’ smash­ing suc­cess at the an­nu­al Amer­i­can So­ci­ety of Clin­i­cal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER